This morning, BTLS announced a first approval of an AGROBODY biocontrol by a U.S. state.Remember that EVOCA merely serves as a proof-of-concept, with the Next Gen candidate ‘EVOCA NG' positioned as the to-be-commercialized asset, with a planned launch in the U.S. in 2029 and in Europe in 2030.FY25 results to be published later this week during which we anticipate more granularity on today's announcement and progress of the ongoing financing round (remember cash runway until May this year - our T ....
